Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast 
Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services 
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers 
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight 
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand 
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War 
Tesla Launches New Model Y Variant in the US Starting at $41,990 
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs 
BEVERLY, Mass. and TORONTO, Aug. 22, 2017 -- Hamilton Thorne Ltd. (TSX-V:HTL) today announced a delay in the release of its financial results for the three and six months ended June 30, 2017 and related conference call in order to allow additional time to conclude the accounting for the period. The Company will announce the timing of the rescheduled conference in a press release concurrent with the release of financial results, which will be delivered within the requisite period. The press release, with accompanying financial information, will be posted on the Company’s website at www.hamiltonthorne.com and on www.sedar.com.
About Hamilton Thorne Ltd. (www.hamiltonthorne.com)
Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.
Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.
For more information, please contact: David Wolf, President & CEO Hamilton Thorne Ltd. 978-921-2050 [email protected] Michael Bruns, CFO Hamilton Thorne Ltd. 978-921-2050 [email protected]
